- The magazine
- Cancer Biology
- Chromatography & Mass Spectrometry
- Contract Research
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & Rapid Micro Methods (RMMs)
- Process Analytical Technology (PAT) & Quality by Design (QbD)
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Cell based assays for screening workshop – May 2014
- Biochemical assays for screening workshop – July 2014
- Cell based assays for screening workshop – November 2014
- 3D cell based assays: Advanced workshop – November 2013
- Chemical Biology, Drug Discovery & Screening workshop – October 2013
- Cell based assays for screening workshop – June 2013
- Biochemical Assays Workshop – April 2013
- Biochemical Assays Workshop 2012
- Pharma industry events
- About us
- Contact us
Alongside established drug target classes, innovative approaches are addressing previously undruggable target classes such as protein–protein interactions.
Whitepaper: Advantages of Online 2D UPLC for MRM Quantification of Therapeutic Monoclonal Antibodies in Serum
This application note demonstrates the development of a two-dimensional chromatographic assay for the quantification of trastuzumab, providing up to a three-fold increase in sensitivity compared to 1D LC/MRM...
It is critical and required for pharmaceutical manufacturers to have quality control procedures in place to ensure incoming raw materials are both correct and meet sufficient quality standards...
Can purchased or free scientific content be reused or shared? Not necessarily, as the free white paper from RightsDirect explains...
Raman spectroscopy can be used to effectively and efficiently identify and distinguish different materials...
App Note: Gattefossé SAS – Investigating the lipolysis of lipid nanoparticles: impact on drug release properties
Author: Gattefossé SAS
Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) are colloidal systems of interest for the delivery of poorly water-soluble drugs...
Author: Cobalt Light Systems
Dr. Carl Anderson of Duquesne University, Pittsburgh, USA has written a white paper about developing transmission Raman methods for content uniformity analysis as an alternative to HPLC analysis...
Author: Freeman Technology
Freeman Technology and GEA Pharma Systems have conducted a study to investigate the feasibility of predicting critical quality attributes (CQA) of tablets from intermediate granule properties...
SmartGene® Fungi is a customisable web service for sequence-base identification, typing and analysis of medical and environmental fungi...
Miniature and cost-effective NIR spectrometers are starting to facilitate QbD adoption...
Author: Bruker Optik
Pharmaceutical manufacturers are required to enhance their critical quality performances. This is being encouraged by the FDA, which is pushing towards using modern process analytical technology (PAT) to ensure the quality of the final product. A large number of applications in the Process Analytical Technology (PAT/QbD) initiative can be addressed using FT-NIR spectroscopy. For drug product sites for instance, NIR spectroscopy can be used at almost every step of tablet manufacture from raw material control over granulation and drying to content uniformity analysis of the dosage unit...
Rigaku's 1064 Nanometer Handheld Raman Analyzers provide increased capability for cell culture media identification...
ABB Analytical Measurement Analytik Jena AG Azbil BioVigilant, Inc. B&W Tek, Inc. bioMérieux BMG LABTECH GmbH Bruker Daltonik GmbH CAMO Software AS Chemspec Europe Ltd CI Precision Dow Chemical Company Ltd EUROGENTEC FOSS NIRSystems, Inc. GE Analytical Instruments IDBS IONICON Analytik GmbH LI-COR Biosciences Natoli Engineering Company, Inc. Pall Life Sciences PhyNexus, Inc. ReAgent Roche Sirius Analytical Instruments Ltd Vala Sciences Veltek Associates Inc. Waters Corporation